CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 18 enrolled
Drug / intervention
Creatinedietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT07033611
NCT07033611N/ACompleted
CompareCT.gov

Effects of Creatine Supplementation in Sarcopenic and Non-sarcopenic Patients on Chronic Hemodialysis

Carla Basualto Alarcón·interventional·Posted Jun 24, 2025·Updated Jun 24, 2025

In Brief

A clinical study evaluating Creatine for Dialysis; Complications and Performance Enhancing Product Use. Completed, enrolled 18 participants across 1 site.

Detailed Summary

Adult patients undergoing chronic dialysis therapy for at least three months were selected. A physical function assessment was conducted, including the Short Physical Performance Battery (SPPB) and a handgrip strength test. Additionally, a bioelectrical impedance analysis was performed. Subsequently, 5 grams of creatine were administered daily for a period of eight weeks, after which the same assessments were repeated. The results were then analyzed to identify any differences in the tests, aiming to detect potential changes following creatine supplementation.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDialysis; Complications, Performance Enhancing Product Use
CountriesChile
Collaborators--

Timeline

N/ACompletedFinished
202420252026
First PostedJun 24, 2025
Enrollment StartJan 1, 2024
Primary CompletionFeb 28, 2024
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 1.0 years ago

Interventions

Creatinedietary

Five grams of creatine were administered to each patient daily for eight weeks.